AcquisitionOther
Gyre Therapeutics acquired Cullgen Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Gyre Therapeutics -> Cullgen Inc. · approximately $300 million
To acquire Cullgen in all-stock transaction for therapeutic development.
Open source record (SEC) ↗